Pacemakers Market By Product (Implantable, (Single Chamber, Dual Chamber, Biventricular) and External) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Failure to restore the normal sinus rhythm of the heart results in an abnormal or ectopic heartbeat, often referred to as cardiac arrhythmia. The arrhythmia is initiated by three discernible etiologies, such as re-entry, automaticity, and triggers. Automaticity occurs due to alterations in the ion exchange at the cellular level. Re-entry occurs when the propagating electric impulse does not fade away and re-excites the heart even after the refractory period is over. Triggered events rarely occur from abnormalities encountered in the heart muscles' ion exchange. Pacemakers are used in patients with cardiac arrhythmias to keep their hearts beating normally.

Pacemakers used for the treatment of irregular heartbeats are segmented as implantable and external. The implantable pacemakers are further categorized as single chamber, dual chamber, and biventricular pacemakers. There is tremendous demand for dual-chamber pacemakers due to their dual ability to stimulate the right atrium and right ventricle. Biventricular pacemakers, also known as cardiac resynchronization therapy (CRT), will serve as a lucrative market in the near future.

Data forecasting and market estimation are used to conduct a country-cross-sectional analysis of the various types of pacemakers available.

Porter's five forces model provides an overview of the competitive rivalry in the pacemaker market. A market assessment provides comprehensive information about the existing business milieu in the pacemaker market. The Key Developments section in the company profiles tracks all the recent mergers, acquisitions, and strategic partnerships between medical device manufacturers to upgrade the technical aspects related to cardiac pacemakers. The product portfolio exhibits the various pacemakers offered by major market players, which include Boston Scientific Corporation, Biotronik, Inc., Cordis, Inc., Medtronic Plc, MEDICO S.p.A., OSCOR, Inc., Pacetronix, St. Jude Medical, Vitatron, and ZOLL Medical Corporation.

Based on product types, the global pacemakers market is categorized into:

  • Implantable
  • Single Chamber
  • Dual Chamber
  • Biventricular
  • External

Pacemakers employ electrical impulses generated by an electrode to facilitate the contraction of the heart muscles. It is a very useful device that is used for regulating the heartbeat. Pacemakers constantly detect a normal heartbeat; when there is no normal heartbeat, they are responsible for stimulating the ventricles with a low-voltage impulse. The recent technological advancements in pacemakers, such as transitional tissue welding, dynamic pacemaking technology, and microprocessor-controlled devices, are contributing to market growth. Implantable pacemakers are currently dominating the market on account of the rising prevalence of cardiac arrhythmia cases (bradycardia, tachycardia, etc.). Furthermore, the pacemakers' multiple leads enable them to restore normal heart function. External pacemakers serve as a potential market for the management of bradyarrhythmias owing to meritorious features such as ergonomic dial design and soft keys to set stimulation parameters. The key players leading the pacemaker market are Boston Scientific Corporation, Biotronik, Inc., Cordis, Inc., Medtronic Plc, MEDICO S.p.A., OSCOR, Inc., Pacetronix, St. Jude Medical, Vitatron, ZOLL Medical Corporation.

For the purpose of this study, the global pacemakers market is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

According to the Centers for Disease Control and Prevention's 2015 report, approximately 2.7 to 6.1 million people in the United States have atrial fibrillation. Around 2% of people below 65 years of age and 9% of people above 65 years of age have atrial fibrillation. The occurrence is more common in people of European descent and less likely to occur in African American individuals. Rising public health awareness and an increasing number of patients being diagnosed with cardiac arrhythmia drive the pacemaker market in North America.

Technological advancements in the development of pacemakers in Western Europe and the rising prevalence of cardiac complications in Eastern Europe drive the pacemaker market in Europe. Asia Pacific will be the most potential regional market during the forecast period from 2018 to 2026, owing to the growing penetration of major medical device companies manufacturing cardiac pacemakers. The affordable reimbursement scenario for cardiac pacemakers also contributes to the growth of the market in the Asia Pacific.

Frequently Asked Question:

The market for Pacemakers Market is expected to reach USD$ 11,372.0 Mn in 2026.

The Pacemakers Market is expected to see significant CAGR growth over the coming years, at 9.32%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Boston Scientific Corporation, Biotronik, Inc., Cordis, Inc., Medtronic Plc, MEDICO S.p.A., OSCOR, Inc., Pacetronix, St. Jude Medical, Vitatron. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Mar 2018
Category:  Medical Devices
Report ID:   59028
Report Format:   PDF
Pages:   120
Rating:    4.1 (15)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support